We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Retroscreen | LSE:RVG | London | Ordinary Share | GB00B6ZM0X53 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 285.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/9/2014 07:56 | I gave up reading after a bit, because of the pattern. They treat employees very badly and are wasting money on hiring/firing. | lennonsalive | |
25/9/2014 18:15 | If those are true reviews, there seem to be sufficient clues for some of those anonymous writers to be identified by management. I've pasted a link onto my shorters thread (DOWN) for others to weigh up. | m.t.glass | |
25/9/2014 14:19 | WAKEY WAKEY Mkt Cap now £190m after recent equity raise keeps the pot boiling....still due a big correction. That's 6-7 x revenue ....and now loss making. Some suckers out there. LONDON--Retroscreen Virology Group PLC (RVG.LN) has swung to a half year loss as the company invests in accelerating its biomarker discovery program. The loss before tax in the six months ended June 30 was 5.4 million pounds ($8.8 million) compared with a profit of GBP0.03 million in the same period last year. Revenue increased by 25% to GBP15.0 million. Research and development expenses rose to GBP3.1 million, from GBP0.5 million, while administrative expenses were up at GBP7.3 million, from GBP2.9 million. | greedyslapheadtrader | |
18/7/2014 21:41 | on a nice leg up... little interest on the boards :-) | andrbea | |
04/3/2014 08:56 | ditto now also using over inflated equity to grow Looks like this latest move adds no earnings recipe for an implosion | greedyslapheadtrader | |
16/12/2013 16:19 | mkt cap £142m t/o £23m loss making logistic constraints on meaningful bus growth mkt thin as an after eight ramping will not work forever do the maths these are going back down to a reasonable valuation down-trend now under-way | greedyslapheadtrader | |
16/12/2013 09:18 | great call mate...deary me!! | miti 1000 | |
13/12/2013 09:41 | penny dropping that fundies have got way ahead of themselves here... | greedyslapheadtrader | |
12/12/2013 15:08 | Looking like a Matterhorn formation under-way - back to the quid soon? | greedyslapheadtrader | |
14/10/2013 13:33 | So play it accordingly - with carefully sized stakes and appropriate bankings along the way. Up 360% in its first 5 months. | m.t.glass | |
26/9/2013 13:34 | looks like a huge ramp to me co valuation almost ten times turnover highly illiquid A CEO whose rhetoric is hard to interpret May well fall to earth at some point - and then there will be carnage as investors try and exit in an orderly fashion | greedyslapheadtrader | |
18/9/2013 08:27 | In today. I have been watching this company for a while a procrastinated over the high valuation. But you get what you pay for, and the rate of recent contract wins, and more importantly the value of these contacts makes it very attractive high growth early stage proposition. | malhashemi | |
22/8/2013 13:20 | As I thought really... it's way, way, way overvalued on the market. IMO, DYOR. | adsuk | |
22/8/2013 13:19 | Just been reading through the half yearly report for IP Group (LN:IPO), this company features heavily in it, and features early on in the report. It's clearly one of the most developed and best performing companies they have in their portfolio, in what has been a so-so year so far for IP Group. They value their 22.7% holding at £22.6m. | adsuk | |
09/8/2013 07:28 | Retroscreen Virology Limited, the global leader in the conduct of Human Viral Challenge Studies, is pleased to announce that the Company will be attending the eighth Options for the Control of Influenza conference at The Cape Town International Convention Centre, Cape Town, South Africa, 4th-9th September 2013 Held every 3 years, Options for the Control of Influenza is the largest international scientific conference exclusively devoted to influenza. See full article at EDIT: Share price up 123.6% since start of 2013. Up 236% since start of thread. Risky metrics though. | m.t.glass | |
24/7/2013 21:29 | Insti holdings are a pain in the A quite honestly. Once they decide to unload the "iceberg effect" can depress the price for weeks. I doubt they will be selling yet though, especially now that the co has attracted new funding. A promising co. | echelon | |
02/7/2013 07:15 | Yesterday, Invesco told us their stake is now increased to 20.2%. Today, Henderson Global Investors tell us they've taken their stake in RVG to 6.34% (last week it was trimmed to 4.75%) | m.t.glass | |
14/6/2013 10:20 | £25m placing at £2....pretty big stuff. f | fillipe | |
26/4/2013 10:52 | Coverage of RVG on the iii discussions is nil and similar on LSE. Today's 18% uptick (45p) adds almost £19m to the mkt cap and give a mkt cap of £118m.....you can't get better notice than that and all without any mentions or RNS's ! I think this goes beyond just testing, with something much greater in the tube. f | fillipe | |
26/4/2013 10:26 | Haven't seen anything on my news alerts today so far. Share price is now up 100% since the start of 2013 | m.t.glass | |
26/4/2013 10:11 | Presumably a tip today, somewhere?.....Inv Chr? f | fillipe | |
26/4/2013 10:08 | Market capitalisation now exceeds the £100m threshold, bringing it to the attention of those funds who won't buy into anything below that level. Up 100% from its pre-Xmas level. | m.t.glass | |
10/4/2013 10:23 | Very happy to be holding here....early days. f | fillipe | |
10/4/2013 08:03 | No obvious shocks among today's Results. Not studied them closely yet. Anyone else have a view? IG are not accepting new upbets at the moment. | m.t.glass |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions